GRANITE BIO is a private biotechnology company located in Basel (Switzerland).
GRANITE BIO is supported by top-tier investors with ~$100M raised to date. Based on fundamental research conducted over the last two decades, GRANITE BIO's is pursuing a differentiated approach to transform inflammatory, autoimmune, and fibrotic conditions. Both our programs are first-in-class monoclonal antibodies for large market opportunities in Immunology and Inflammation. GRT-001, the lead asset, is a CCR2-mediated monocyte depleter that has just completed a Phase 1a trial in healthy volunteers and has shown favorable safety and pharmacodynamic effect. The Phase 1b trial in patients with Ulcerative Colitis has just started. GRT-002 is an IL-3 neutralizing antibody that is thought to play an important role in type II inflammation.
Our company fosters an open, inter-disciplinary, diverse, international and creative working environment. We enable work-from-home options according to our internal workflows. The successful candidate will be highly motivated and enthusiastic with a positive "can do" attitude, attention to details and innovation, strong organizational and communication skills. As a key member of our team, you will be responsible for all finance-related matters in a fast-paced, collaborative environment. Leveraging your corporate finance expertise, you will support the organizational development of GRANITE BIO and develop creative, implementable solutions for complex challenges. You will collaborate closely with scientific teams, aligning corporate finance goals with project management initiatives to ensure efficient governance and smooth operations. With empathy, strong communication skills and natural assertiveness, you will promote trust and implement decisions clearly and in a team-oriented manner.
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.